ALK-Abelló A/S
CPSE:ALK B
kr 153.50
+ kr1.10 (0.72%)
kr 153.50
+ kr1.10 (0.72%)
End-of-day quote: 05/07/2024

ALK B: Global investment alternatives & competitors

Competitors

Ticker Price Forecast 1Y Forecast 2Y Market Cap Div Yld Growth Rate
ENXTBR:ARGX
argenx
367.60 0% 0% 21,771.11 0% 0%
CPSE:GMAB
Genmab A/S
2003.00 67.18% 127.63% 129,957.65 0% 22.71%
BIT:REC
Recordati Industria Chimica e Farmaceutica
S.p.A.
51.20 28.98% 42.6% 10,301.34 2.38% 10.37%
CPSE:ZEAL
Zealand Pharma A/S
660.00 0% 0% 39,420 0% 0%
LSE:HIK
Hikma Pharmaceuticals PLC
19.56 27.52% 40.63% 4,348.95 2.92% 10.04%
HLSE:ORNBV
Orion Oyj
36.11 24.7% 68.44% 5,038.85 4.5% -0.43%
ENXTPA:VIRP
Virbac
348.50 28.36% 43.34% 2,904.29 0.37% 43.8%
XTRA:MOR
MorphoSys
66.80 0% 0% 2,493.27 0% 0%
LSE:INDV
Indivior PLC
14.22 -23.61% -1.68% 1,952.43 0% -2.7%
BME:ALM
Almirall
8.87 -40.61% 37.83% 1,794.5 2.2% 2.38%
XTRA:EVT
Evotec
9.54 -32.05% 101.29% 1,726.81 0% 0%
SWX:COPN
Cosmo Pharmaceuticals N.V.
71.90 -10.68% 47.56% 1,160.62 2.69% -76.88%
BME:FAE
Faes Farma
3.50 14.51% 24.13% 1,089.37 4.45% 6.96%
BME:PHM
Pharma Mar
31.56 0% 0% 536.95 2.06% -39.63%
BUL:SFA
Sopharma AD
6.06 0% 0% 997.04 15.1% 80.58%
SWX:BSLN
Basilea Pharmaceutica
40.70 -15.89% -17.77% 474.13 0% 0%
ENXTPA:DBV
DBV Technologies
1.22 0% 0% 119.69 0% 0%
SWX:MOLN
Molecular Partners
3.17 0% 0% 110.77 0% 0%